![Jonathan Terrett](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jonathan Terrett
No open positions remaining
Profile
Jonathan Alexander Terrett worked as Director at Oxford GlycoSciences Plc from 1999 to 2012.
Served as Director at Medarex, Inc. from 2004 to 2009.
Held the position of Director at Oxford BioTherapeutics Ltd. from 2013 to 2014.
Worked as Director at Celltech R&D Ltd. Held the role of Principal at Smithkline Beecham Plc.
Served as Vice President-Oncology Discovery at CytomX Therapeutics Holdings LLC.
Worked as Head-Immuno Oncology Research & Translation at CRISPR Therapeutics AG.
Dr. Terrett completed undergraduate studies at The University of Sheffield and earned a doctorate from The University of Nottingham in 1996.
Former positions of Jonathan Terrett
| Companies | Position | End |
|---|---|---|
Oxford BioTherapeutics Ltd.
 Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops antibody-based medicines for oncology | Chief Tech/Sci/R&D Officer | 2013-07-28 |
Medarex, Inc.
 Medarex, Inc. BiotechnologyHealth Technology Provides antibody and oncology drug development services | Director/Board Member | 2009-10-31 |
Celltech R&D Ltd.
 Celltech R&D Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in drug discovery and development | Director/Board Member | - |
CytomX Therapeutics Holdings LLC
 CytomX Therapeutics Holdings LLC Pharmaceuticals: MajorHealth Technology Engaged in the development of new generation targeted antibody therapeutics | Corporate Officer/Principal | - |
| CRISPR THERAPEUTICS AG | Chief Tech/Sci/R&D Officer | - |
Training of Jonathan Terrett
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
88
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Medarex, Inc.
Medarex, Inc. BiotechnologyHealth Technology Provides antibody and oncology drug development services | Health Technology |
Smithkline Beecham Plc
 Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Oxford BioTherapeutics Ltd.
Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops antibody-based medicines for oncology | Health Technology |
Oxford GlycoSciences Plc
 Oxford GlycoSciences Plc Pharmaceuticals: MajorHealth Technology Developes and manufactures novel products for the diagnosis and treatment of human disease | Health Technology |
The University of Sheffield
 The University of Sheffield Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Nottingham
 The University of Nottingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CytomX Therapeutics Holdings LLC
CytomX Therapeutics Holdings LLC Pharmaceuticals: MajorHealth Technology Engaged in the development of new generation targeted antibody therapeutics | Health Technology |
Celltech R&D Ltd.
Celltech R&D Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in drug discovery and development | Commercial Services |
CRISPR Therapeutics AG
 CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines | Health Technology |
- Stock Market
- Insiders
- Jonathan Terrett
